Skip to main content

Table 2 CMR finding in ESRD patients suffered and free of HF

From: RETRACTED ARTICLE: Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging

  Normal healthy (n = 25) ESRD free of HF (n = 40) ESRD Suffered HF (n = 26)
LV function
 EF (%) 64.99 ± 4.43 58.10 ± 6.99a 45.77 ± 17.04a,b
 EDV (ml) 116.45 ± 31.32 122.22 ± 32.25 155.08 ± 63.04a
 ESV (ml) 42.07 ± 9.14 52.05 ± 16.86 92.58 ± 70.56a,b
 SV (ml) 78.65 ± 16.60 69.84 ± 19.17 61.73 ± 19.52a,b
 Mass(g) 51.79 ± 17.31 84.63 ± 31.75 95.03 ± 29.95a,b
Myocardial strain
 GRS (%) 43.13 ± 10.66 43.40 ± 14.74 31.89 ± 16.20a,b
 GCS (%)a −18.61 (−20.25, −16.90) −18.91 (− 20.92, − 16.70) −17.10 (− 19.04, − 12.31)a,b
 GLS (%) −16.68 ± 2.90 −15.99 ± 3.36 −12.96 ± 4.98a,b
Presence of LGE
 Non-presence (n, %) N/A 2 (5.00%) 0
 Patchy (n, %) N/A 17 (42.50%) 7 (26.92%)
 Diffused (n, %) N/A 21 (52.50%) 19 (73.08%)
 Total enhanced volume>5SD(ml) N/A 14.62 ± 12.79 23.13 ± 13.10b
 LGE Extent>5SD(%) N/A 13.92 ± 12.18 22.04 ± 12.47b
T1maps
 Native T1 values (ms) 1276.35 ± 56.56 1319.39 ± 55.44a 1360.10 ± 50.14a,b
 Post-contrast T1 values (ms) 502.91 ± 30.76 497..74 ± 74.24 510.24 ± 71.21
 λ (%) 49.79 ± 3.79 48.80 ± 5.81a 51.06 ± 6.24a,b
 ECV (%) 26.97 ± 1.87 31.85 ± 3.01a 35.42 ± 4.42a,b
  1. Values are mean ± SD or n (%) or median (quartile) as appropriate. aP < 0.05 vs. normal; bP < 0.05 vs. ESRD free from HF. CMR cardiac magnetic resonance, HF heart failure, LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, GRS global radial strain, GCS global circumferential strain, GLS global longitudinal strain, LGE late gadolinium enhancement, ECV extra cellular volume. All the other abbreviations are the same as the Table 1